115 related articles for article (PubMed ID: 9874177)
1. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor.
Goumain M; Voisin T; Lorinet AM; Balasubramaniam A; Laburthe M
Eur J Pharmacol; 1998 Dec; 362(2-3):245-9. PubMed ID: 9874177
[TBL] [Abstract][Full Text] [Related]
2. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
3. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.
Goumain M; Voisin T; Lorinet AM; Ducroc R; Tsocas A; Rozé C; Rouet-Benzineb P; Herzog H; Balasubramaniam A; Laburthe M
Mol Pharmacol; 2001 Jul; 60(1):124-34. PubMed ID: 11408607
[TBL] [Abstract][Full Text] [Related]
4. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis.
Voisin T; Rouyer-Fessard C; Laburthe M
Am J Physiol; 1990 May; 258(5 Pt 1):G753-9. PubMed ID: 2159240
[TBL] [Abstract][Full Text] [Related]
5. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
6. Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide.
Laburthe M; Chenut B; Rouyer-Fessard C; Tatemoto K; Couvineau A; Servin A; Amiranoff B
Endocrinology; 1986 May; 118(5):1910-7. PubMed ID: 3009142
[TBL] [Abstract][Full Text] [Related]
7. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
8. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.
Balasubramaniam A; Tao Z; Zhai W; Stein M; Sheriff S; Chance WT; Fischer JE; Eden PE; Taylor JE; Liu CD; McFadden DW; Voisin T; Roze C; Laburthe M
J Med Chem; 2000 Sep; 43(18):3420-7. PubMed ID: 10978189
[TBL] [Abstract][Full Text] [Related]
10. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon.
Pheng LH; Perron A; Quirion R; Cadieux A; Fauchère JL; Dumont Y; Regoli D
Eur J Pharmacol; 1999 Jun; 374(1):85-91. PubMed ID: 10422644
[TBL] [Abstract][Full Text] [Related]
12. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
Widdowson PS
Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
[TBL] [Abstract][Full Text] [Related]
13. The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors.
Gehlert DR; Gackenheimer SL; Schober DA; Beavers L; Gadski R; Burnett JP; Mayne N; Lundell I; Larhammar D
Eur J Pharmacol; 1996 Dec; 318(2-3):485-90. PubMed ID: 9016942
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization.
Allen CJ; Ghilardi JR; Vigna SR; Mannon PJ; Taylor IL; McVey DC; Maggio JE; Mantyh PW
Neuroscience; 1993 Apr; 53(3):889-98. PubMed ID: 7683778
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
Dubinion JH; Mi Z; Zhu C; Gao L; Jackson EK
Hypertension; 2006 Mar; 47(3):545-51. PubMed ID: 16365188
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
Rodriguez M; Audinot V; Dromaint S; Macia C; Lamamy V; Beauverger P; Rique H; Imbert J; Nicolas JP; Boutin JA; Galizzi JP
Biochem J; 2003 Feb; 369(Pt 3):667-73. PubMed ID: 12398768
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs.
Borowsky B; Walker MW; Bard J; Weinshank RL; Laz TM; Vaysse P; Branchek TA; Gerald C
Regul Pept; 1998 Sep; 75-76():45-53. PubMed ID: 9802393
[TBL] [Abstract][Full Text] [Related]
19. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides.
Parker SL; Parker MS; Buschauer A; Balasubramaniam A
Eur J Pharmacol; 2003 Aug; 474(1):31-42. PubMed ID: 12909193
[TBL] [Abstract][Full Text] [Related]
20. Identification of multiple neuropeptide Y receptor subtypes in the human frontal cortex.
Statnick MA; Schober DA; Gehlert DR
Eur J Pharmacol; 1997 Aug; 332(3):299-305. PubMed ID: 9300264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
